InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,254.64
(
0.01%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: DonShimoda post# 154192

Saturday, 12/15/2012 4:06:51 PM

Saturday, December 15, 2012 4:06:51 PM

Post# of 252302
I just realized that my post #msg-82505647 implied that Ariad's Iclusig's MMR was achieved in just 12-months. Just to be clear, the MMR data I referenced was based on 24 and 30 months for tasigna and iclusig, respectively. Unfortunately, I was unable to find an apples-apples comparison (e.g same line of therapy/same time period). However, just to put Iclusig's 51% MMR in 3/4 line in context, in a front-line setting, gleevec has a 3-year MMR of around 53%.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up